93 related articles for article (PubMed ID: 12862319)
1. Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1.
Deng L; Yang J; Zhao XR; Deng XY; Zeng L; Gu HH; Tang M; Cao Y
Cell Res; 2003 Jun; 13(3):187-94. PubMed ID: 12862319
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways.
Liu HD; Zheng H; Li M; Hu DS; Tang M; Cao Y
Cell Signal; 2007 Feb; 19(2):419-27. PubMed ID: 16979873
[TBL] [Abstract][Full Text] [Related]
3. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
4. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
Blake SM; Eliopoulos AG; Dawson CW; Young LS
Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
[TBL] [Abstract][Full Text] [Related]
5. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
Liu B; Chen XY
Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
7. [Construction and function analysis of a CTAR-2 region mutant of the Epstein-Barr virus-encoded latent membrane protein-1].
He ZM; Chen ZC
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):261-5. PubMed ID: 12621551
[TBL] [Abstract][Full Text] [Related]
8. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
10. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
11. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
13. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
[TBL] [Abstract][Full Text] [Related]
14. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
16. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
Liao W; Tang M; Yin L
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):199-201. PubMed ID: 11783085
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.
Liu MT; Chang YT; Chen SC; Chuang YC; Chen YR; Lin CS; Chen JY
Oncogene; 2005 Apr; 24(16):2635-46. PubMed ID: 15829976
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
[TBL] [Abstract][Full Text] [Related]
19. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
[TBL] [Abstract][Full Text] [Related]
20. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
Tao Y; Song X; Deng X; Xie D; Lee LM; Liu Y; Li W; Li L; Deng L; Wu Q; Gong J; Cao Y
Exp Cell Res; 2005 Feb; 303(2):240-51. PubMed ID: 15652339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
